Comprehensive investigation of a new signature integrating lipid metabolism and immune-related genes for clear cell renal cell carcinoma prognosis and immunometabolism landscapes
This analysis uncovers distinct prognostic pathways in clear cell renal cell carcinoma, suggesting new therapeutic strategies through lipid metabolism and immune gene interactions.
Key Points
The study reveals that distinct lipid metabolism phenotypes offer favorable prognosis and enhanced anti-tumor immunity in ccRCC patients.
Through systemic analysis, two unique molecular subtypes were identified, with one showing better survival outcomes and immunotherapy response.
An innovative lipid-immune score (LIS) has been developed as a reliable predictor for overall survival and immunotherapy effectiveness.
The research highlights the importance of lipid metabolism in the tumor microenvironment, suggesting a novel approach to therapeutic management in ccRCC.